Skip to main content
. 2017 Jan 23;12(1):e0170630. doi: 10.1371/journal.pone.0170630

Fig 2. GATA2 is upregulated during the progression of clinical patients’ AML cells and KG1a cells treated with drugs.

Fig 2

(A) GATA2 mRNA expression in peripheral primary AML cells and chemo treatment AML cells were determined by real time PCR. (B) Western blot detected the GATA2 protein level in two groups as described in Fig 2A. (C) Real time PCR identified GATA2 mRNA expression level with Geftinib(10 μM) or Cerubidine(1 μM) treatment in KG1a cells. (D) GATA2 protein expression after KG1a cells were treated by Geftinib(10 μM) or Cerubidine(1 μM) at different times. ***P <0.001.